Brain Tumors Research - Symptoms, Benign and Malignant Tumors, Gliomas, Screening, Treatment

Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.


Brain Tumors Research Today

Home

View Latest Issue

Information About Brain Tumors

Books on Brain Tumors

Advertising in Research Today

View Other Research Today Publications



Volume 4 (2007), Issue 9 (September)

  1. Monitoring brain tissue oxymetry: will it change management of critically ill neurologic patients?
    J Neurol Sci, 261(1): 1-9. [Abstract] [Full-text]
  2. Hyperventilation-induced nystagmus in peripheral vestibulopathy and cerebellopontine angle tumor.
    Neurology, 69(10): 1050-9. [Abstract] [Full-text]
  3. Development of bionanocapsules targeting brain tumors.
    J Control Release, 122(2): 159-64. [Abstract] [Full-text]
  4. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
    Cancer, 110(6): 1345-50. [Abstract] [Full-text]
  5. Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.
    Cancer, 110(6): 1329-37. [Abstract] [Full-text]
  6. Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma.
    Neurology, 69(11): 1178-82. [Abstract] [Full-text]
  7. Cloning and characterization of human RTVP-1b, a novel splice variant of RTVP-1 in glioma cells.
    Biochem Biophys Res Commun, 362(3): 612-8. [Abstract] [Full-text]
  8. Connexin 43 confers resistance to hydrogen peroxide-mediated apoptosis.
    Biochem Biophys Res Commun, 362(3): 747-52. [Abstract] [Full-text]
  9. O (4)-benzylfolic acid inactivates O (6)-alkylguanine-DNA alkyltransferase in brain tumor cell lines.
    Cancer Chemother Pharmacol, 60(6): 883-9. [Abstract] [Full-text]
  10. Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas.
    Cancer Gene Ther, 14(10): 836-46. [Abstract] [Full-text]
  11. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study.
    Int J Radiat Oncol Biol Phys, 69(2): 589-97. [Abstract] [Full-text]
  12. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Int J Radiat Oncol Biol Phys, 69(2): 404-10. [Abstract] [Full-text]
  13. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.
    Int J Radiat Oncol Biol Phys, 69(2): 381-9. [Abstract] [Full-text]
  14. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Int J Radiat Oncol Biol Phys, 69(2): 390-6. [Abstract] [Full-text]
  15. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death.
    J Natl Cancer Inst, 99(18): 1410-4. [Abstract] [Full-text]
  16. Temozolomide in pediatric low-grade glioma.
    Pediatr Blood Cancer, 49(6): 808-11. [Abstract] [Full-text]
  17. Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
    J Control Release, 122(3): 356-63. [Abstract] [Full-text]
  18. Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics.
    J Control Release, 122(3): 315-23. [Abstract] [Full-text]
  19. Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.
    J Surg Res, 142(2): 268-74. [Abstract] [Full-text]
  20. Glioma invasiveness responds variably to irradiation in a co-culture model.
    Int J Radiat Oncol Biol Phys, 69(3): 880-6. [Abstract] [Full-text]
  21. Connexin43 enhances glioma invasion by a mechanism involving the carboxy terminus.
    Glia, 55(15): 1554-64. [Abstract] [Full-text]
  22. Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme.
    Int J Radiat Oncol Biol Phys, 69(3): 831-8. [Abstract] [Full-text]
  23. Diffusion tensor magnetic resonance imaging finding of discrepant fractional anisotropy between the frontal and parietal lobes after whole-brain irradiation in childhood medulloblastoma survivors: reflection of regional white matter radiosensitivity?
    Int J Radiat Oncol Biol Phys, 69(3): 846-51. [Abstract] [Full-text]
  24. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Int J Radiat Oncol Biol Phys, 69(3): 839-45. [Abstract] [Full-text]
  25. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Int J Radiat Oncol Biol Phys, 69(3): 825-30. [Abstract] [Full-text]
  26. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
    Int J Radiat Oncol Biol Phys, 69(3): 820-4. [Abstract] [Full-text]
  27. Outcome in adult low-grade glioma: the impact of prognostic factors and treatment.
    Neurology, 69(13): 1366-73. [Abstract] [Full-text]
  28. Effect of prophylactic ondansetron on postoperative nausea and vomiting in patients on preoperative steroids undergoing craniotomy for supratentorial tumors.
    J Neurosurg Anesthesiol, 19(4): 239-42. [Abstract] [Full-text]
  29. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
    Cancer, 110(7): 1542-50. [Abstract] [Full-text]
  30. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Cancer, 110(7): 1551-9. [Abstract] [Full-text]
  31. CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation.
    Nat Clin Pract Oncol, 4(10): 603-7. [Abstract] [Full-text]
  32. Long-term survival with glioblastoma multiforme.
    Brain, 130: 2596-606. [Abstract] [Full-text]
  33. Allergic conditions and brain tumor risk.
    Am J Epidemiol, 166(8): 941-50. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Brain Tumors Research Today. All Rights Reserved.



Brain Tumors Research Today Archive:

Volume 1 (2004)
  Issue 1 (August)
  Issue 2 (September)
  Issue 3 (October)
  Issue 4 (November)
  Issue 5 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)



Brain Tumors Books

Never Change

Never Change